Trinity Biotech plc (ADR) (NASDAQ:TRIB)

CAPS Rating: 5 out of 5

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Recs

0
Player Avatar maryandtommy (36.02) Submitted: 9/8/2008 10:55:35 AM : Outperform Start Price: $4.40 TRIB Score: +153.69

I work in health care, and I believe point of care diagnostics is the wave of the future, as it has clear advantages for both the patient and the heatlth care industry, from convenience to time and cost efficiency.

Featured Broker Partners


Advertisement